Form 8-K · Current report
Martin Marietta Materials 8-K, filed Sep 16, 2026
- Filed
- CIK
- 0000916076
- Accession no.
- 0000950157-26-001024
Summary
Martin Marietta Materials and its subsidiary Martin Marietta Funding LLC entered into the Eighteenth Amendment to their Credit and Security Agreement with Truist Bank, successor by merger to SunTrust Bank, extending the $500 million trade receivables securitization facility's scheduled maturity to September 15, 2027. Borrowings under the facility now bear interest at Adjusted Term SOFR plus 0.700%.
Key points
- The amendment extends the facility's scheduled maturity date to September 15, 2027.
- The facility is a $500 million trade receivables securitization backed by receivables originated by Martin Marietta Materials or certain subsidiaries and held by Martin Marietta Funding LLC.
- The facility may be increased to as much as $700 million subject to lender commitments and other conditions.
- Borrowings by Martin Marietta Funding LLC now bear interest at Adjusted Term SOFR plus 0.700%.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 1.01Entry into a Material Definitive Agreement
- 9.01Financial Statements and Exhibits
From the filing
Item 1.01. Entry into a Material Definitive Agreement On September 15, 2026, Martin Marietta Materials, Inc., (the “Corporation”) and its wholly-owned subsidiary, Martin Marietta Funding LLC (“MM Funding”), entered into the Eighteenth Amendment (the “Eighteenth Amendment”) to its Credit and Security Agreement with Truist Bank, successor by merger to SunTrust Bank (the “Administrative Agent”), dated as of April 19, 2013 (the Credit and Security Agreement, as amended, the “Credit and Security Agreement”). Pursuant to the Eighteenth Amendment, the scheduled maturity date of the facility was extended to September 15, 2027. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.